AlphaGrep UK’s Halozyme HALO Stock Holding History

AlphaGrep UK’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$340K	Buy	+4,348	New	+$296K	0.1%	402
2026 Q1	–	Sell	-3,128	Closed	-$211K	–	851
2025 Q4	$211K	Buy	+3,128	New	+$210K	0.07%	609

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

AlphaGrep UK's HALO Position: Q2 2026 in Review

AlphaGrep UK opened a new position in Halozyme (HALO) in Q2 2026: 4,348 shares worth $340K. The stake represents 0.1% of the portfolio and ranks #402 among its holdings. This is a return to the name: AlphaGrep UK previously reported a position in HALO as recently as Q4 2025.

AlphaGrep UK first reported a position in HALO in Q4 2025 and has held it in 2 quarters since. 629 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

AlphaGrep UK held 4,348 shares of Halozyme worth $340K as of Q2 2026.
Halozyme was a new AlphaGrep UK position in Q2 2026.
Halozyme made up 0.1% of AlphaGrep UK's portfolio in Q2 2026, its #402 holding.
AlphaGrep UK first reported a position in Halozyme in Q4 2025 and has held it in 2 quarters since.
629 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.